Navigation Links
Doctors closer to using gene analysis to help trauma patients

A genetic tool with the potential to identify which trauma and burn patients are most likely to become seriously ill has worked consistently in a wide range of experimental clinical settings ?an important hurdle to overcome before the method is routinely used in emergency rooms and intensive care units.

In a report published today (March 7) in the Proceedings of the National Academy of Sciences, researchers from eight institutions, including the University of Florida, describe how they were able to consistently analyze which genes are active in patients with serious infections or traumatic injuries.

Researchers want to understand the genetic features that enhance a patient’s recovery as well as the elements that cause people to die sometimes weeks after an injury occurs. Identifying those factors could help physicians choose the best treatment, a decision that could mean the difference between life and death, according to UF Genetics Institute scientists.

“The vast majority of patients who experience severe trauma or burn injuries actually do well,?said Lyle Moldawer, a surgery professor in UF’s College of Medicine. “They’re resuscitated at the scene, taken to the hospital, have an uneventful recovery and they’re discharged. But there’s a certain fraction who go on to develop complications that lead to organ failure and death, which is the most common cause of death after traumatic injury ?sepsis and multisystem organ failure. So the goal is to use functional genomics as a tool to identify those patients who, after severe trauma and burn injury, will go on to manifest this multisystem organ failure. It’s a way to better characterize the nature of the immuno-inflammatory response to trauma.?/p>

Dr. Ronald G. Tompkins, a surgeon and biomedical engineer at Massachusetts General Hospital, is leading the effort to develop standard operating procedures for the care of burn and trauma patients and increase understanding of the body’s molecular re actions to injury, including inflammation. The lead research author is Dr. J. Perren Cobb, an associate professor of surgery at Washington University in St. Louis.

Traumatic injuries claim hundreds of thousands of lives each year in the United States. In addition, millions of patients are hospitalized, at an annual cost to society of more than $200 billion. Patients may face a long and difficult recovery period riddled with many potentially fatal complications along the way.

“What we have shown is medical professionals can collect blood and tissue samples from patients, process them at different institutions and get consistent results,?said Henry Baker, associate director of the UF Genetics Institute and interim chairman of molecular genetics and microbiology. “For any tool used in clinical medicine, it’s important that people are able to get the same answers wherever the tool is being used.?/p>

Genomic analyses took place at UF, the Stanford Genome Technology Center and Washington University in St. Louis. Overall data analysis was based at Massachusetts General Hospital at Harvard Medical School.

Specially trained clinical personnel sampled whole blood and other available tissues from more than 200 severely traumatized or burned patients and 23 healthy individuals in an effort to correlate molecular markers with white blood cell behavior, and ultimately, with patient outcome. Studies in healthy patients were conducted at UF, Washington University in St. Louis, the University of Rochester School of Medicine and the University of Medicine and Dentistry of New Jersey. Patients with severe traumatic injuries were studied at the University of Washington at Seattle and the University of Rochester.

In the end, scientists could see dramatic changes in genes turning on and off in trauma victims compared with healthy people. Among the trauma patients, researchers say “analytical noise??differences attributable to the testing method ?was no t significant, suggesting that profiling gene reactions may provide meaningful information to doctors.

The next step is for scientists to continue the experimental procedures in larger multicenter trials, following hundreds of patients over time to describe the molecular profile of healing in response to burns and traumatic injury, researchers say.


Source:University of Florida

Related biology news :

1. Doctors should stop prescribing antibiotics for the common cold, review advises
2. New Discovery May Help Doctors Treat Infertility
3. Chemicals in tattoo inks need closer scrutiny
4. Proteomics brings researchers closer to understanding microbes that produce acid mine drainage
5. Scientists closer to new cancer detection method
6. Stroke treatment a step closer after trial
7. Sperm stem cells closer to being like embryonic stem cells
8. Scientists a step closer to protecting worlds most important crop
9. Scientists one step closer to cancer vaccine
10. UC Davis researchers move biotechnology closer to replacing electronic pacemakers
11. Producing bio-ethanol from agricultural waste a step closer
Post Your Comments:

(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... -- Daon, a global leader in mobile biometric authentication ... version of its IdentityX Platform , IdentityX v4.0. ... have already installed IdentityX v4.0 and are seeing ... UAF certified server component as an option and ... These customers include some of the largest and most ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... ALEXANDRIA, Va. , Dec. 1, 2015 ... provides senior debt to life sciences and healthcare services ... senior secured term loan with MDRejuvena, Inc. ("the Company"). ... commercialization and continued development of the Company,s Rejuvaphyl™ and ... --> Rejuvaphyl is the MDRejuvena brand of high ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... announces Park NX10 SICM Module, an add-on scanning ion conductance microscopy module to ... of SICM to an AFM. , Park SICM benefits virtually all materials characterization ...
(Date:12/1/2015)... , Dec. 1, 2015 Cepheid (Nasdaq: ... its participation at the Piper Jaffray Healthcare Conference in ... morning, the Company is reaffirming its outlook for the ... 2016, in addition to discussing longer term business model ... Chief Executive Officer.  "We continue to be the fastest ...
(Date:12/1/2015)... , December 1, 2015 ... addition of the  "2016 U.K. Virology and ... Forecasts for 100 Tests, Supplier Shares by ...  report to their offering.  --> ... the  "2016 U.K. Virology and Bacteriology Testing ...
Breaking Biology Technology: